IRF3 and neoplasm: Here we showed that the OGT inhibitor OSMI-1 induced DNA damage and cytosolic DNA accumulation which led to activation of the cGAS-STING-TBK1-IRF3 pathway, then enhanced the innate and adaptive immune responses to tumor cells, which reversed the immunosuppressive TME by increasing CD8+ T cells infiltration.